Open original FDA record ↗Recall record
- FDA identifier
- Z-1134-2026
- Company in FDA record
- Intuitive Surgical, Inc.
- FDA classification date
- Jan 21, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Due to probe bags that may have a compromised or incomplete sterile pouch seal.
Source facts
- Action
- On 12/19/2025, the firm emailed to customer an "Urgent Medical Device Recall" letter informing them that Intuitive has identified that some Vision Probe Bags may have a compromised or incomplete sterile pouch seal. Investigation determined that during the supplier manufacturing and packaging process, the Vision Probe Bag is placed into a separate sterile pouch for sealing. During this step, air trapped inside the Vision Probe Bag can remain within the pouch and expand during sterilization, which may place stress on the sterile-pouch seals and result in partial seal failure, creating a potential sterility breach. Customers are instructed: 1. Identify affected product: Inspect the product label and confirm the product number and lot number. a. Appendix A lists affected Part Numbers and Lot Numbers b. Appendix B provides an example label highlighting the location of the Part Number and Lot Number. 2. If the label displays lot numbers within the affected range shown in Appendix A, inspect the product pouch seal. Do not use the product if the seal is compromised or has an incomplete seal and scrap the affected units in accordance with your facility s disposal procedures. 3. Contact Intuitive Customer Service to obtain credit for any scrapped units. a. Product return to Intuitive is not required. 4. Retain a copy of this letter and the complete Acknowledgment Form for your records. 5. Ensure all relevant personnel within your facility are informed of this correction. For Questions - " North and South America: (800) 876-1310, Option 3 (4 am to 5 pm PST) or mail: customerservice@intusurg.com. " Europe, Middle East, Asia and Africa: +800 0821 2020 or +41 21 821 2020 (8 am to 6 pm CET) or eucs@intusurg.com " South Korea: 02-3271-3200 (9 am to 6 pm KSTJ) or support.korea@intusurg.com " Japan: 0120-56-5635 or 03-5575-1362 (9 am to 6 pm JST) or csjapan@intusurg.com " India: +1-800-103-6952 (9 am to 6 pm IT) Taiwan: +0800-86-8181 (9 am to 6 pm CT)
- Initiated
- 2025-12-04
- Root cause
- Process control
- Distribution
- U.S.: AL, AK, AZ, AR, CA, CO, CT, DE, DC, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MA, MD, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, and WY. O.U.S.: Australia, China, France, Germany, Italy, Japan, South Korea, Spain, Switzerland, and United Kingdom
- Recall number
- Z-1134-2026
- Recall status
- Open, Classified
- CDRH record ID
- 217909
- FDA classified
- 2026-01-21
- Recall event number
- 98215